Home » Clinical Trials »  Search Clinical Trials

Therapeutic Areas:  |  Gastroenterology  |  Family Medicine

Search Medical Condition
Please enter condition
Please choose location
Clear Trial Filters
 

Gastroparesis Clinical Trials

A listing of Gastroparesis medical research trials actively recruiting patient volunteers. Search for closest city to find more detailed information on a research study in your area.

RESULTS

Found (8) clinical trials

Diabetic Gastroparesis creates feelings of bloating, nausea, vomiting and pain.

Phase N/A

0099 : A Multicenter, Double-Blind, Randomized, Placebo-Controlled, Parallel-Group Phase 2 Study to Assess the Efficacy, Safety, and Tolerability of Velusetrag for the Treatment of Diabetic or Idiopathic Gastroparesis.

Phase N/A

A clinical trial is being conducted to assess the safety and efficacy of a treatment for patients with diabetic and non-diabetic gastroparesis.

Phase N/A

Gastroparesis creates feelings of bloating, nausea, vomiting and pain. Wake Research Associates is enrolling volunteers with idiopathic or diabetic gastroparesis in a study testing an investigational medication.

Phase N/A

Do you suffer from gastroparesis? You may qualify for a clinical research study. Gastroparesis creates feelings of bloating, nausea, vomiting and pain. ClinSearch is enrolling volunteers with idiopathic or diabetic gastroparesis in a study testing an investigational medication.

Phase N/A

Gastroparesis creates feelings of bloating, nausea, vomiting and pain. ClinSearch is enrolling volunteers in a study testing for individuals with diabetic or idiopathic gastroparesis.

Phase N/A

Gastric Pacemaker Implantation for Gastroparesis

Due to HUD status, this protocol is for implant only. This is NOT a clinical trial.

Phase N/A

Domperidone for Refractory Gastrointestinal Disorders

Domperidone is a dopamine-2 receptor antagonist. It acts as a prokinetic agent through its effects on the chemoreceptor trigger zone and the motor function of the stomach and small intestines. It does not cause any adverse neurological symptoms and has an excellent safety profile for long-term oral administration in recommended ...

Phase N/A